Botulinum Toxins, Type A Completed Phase 1 Trials for Ropivacaine (DB00296)

Also known as: Botulinum Toxin Type A / Type A Botulinum Toxin

IndicationStatusPhase
DBCOND0070419 (Botulinum Toxins, Type A)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03054610Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis.Treatment